TNF-related apoptosis-inducing ligand (TRAIL) and erythropoiesis:: a role for PKCε

被引:0
|
作者
Vitale, M
Gobbi, G
Mirandola, P
Ponti, C
Sponzilli, I
Rinaldi, L
Manzoli, FA
机构
[1] Univ Parma, Osped Maggiore, Dept Anat Pharmacol & Forens Med, Human Anat Sect, I-43100 Parma, Italy
[2] Univ Trieste, Dept Normal Human Morphol, I-34127 Trieste, Italy
[3] Univ Bologna, Dept Anat Sci, I-40126 Bologna, Italy
来源
EUROPEAN JOURNAL OF HISTOCHEMISTRY | 2006年 / 50卷 / 01期
关键词
PKC epsilon; erythropoiesis; EPO; CD34; apoptosis; TRAIL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of the hematopoietic stem cell pool size and the processes of cell differentiation along the hematopoietic lineages involve apoptosis. Among the different factors with a recognized activity on blood progenitor cells, TRAIL a member of the TNF family of cytokines - has an emerging role in the modulation of normal hematopoiesis. PKC epsilon levels are regulated by EPO in differentiating erythroid progenitors and control the protection against the apoptogenic effect of TRAIL. EPO-incluced erythroid CD34 cells are insensitive to the apoptogenic effect of TRAIL between day 0 and day 3, due to the lack of specific surface receptors expression. Death receptors appear after day 3 of differentiation and consequently erythoid cells become sensitive to TRAIL up to day 9/10, when the EPO-driven up-regulation of PKC epsilon intracellular levels inhibits the TRAIL-mediated apoptosis, via Bcl-2. In the time interval between day 3 and 9, therefore, the number of erythroid progenitors can be limited by the presence of soluble or membrane-bound TRAIL present in the bone marrow microenvironment.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 50 条
  • [41] Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
    Micheau, Olivier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (03)
  • [42] Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand
    Secchiero, P
    Gonelli, A
    Carnevale, E
    Corallini, F
    Rizzardi, C
    Zacchigna, S
    Melato, M
    Zauli, G
    NEOPLASIA, 2004, 6 (04): : 364 - 373
  • [43] Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies
    Inoue, S
    MacFarlane, M
    Harper, N
    Wheat, LMC
    Dyer, MJS
    Cohen, GM
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (Suppl 2): : S193 - S206
  • [44] Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies
    S Inoue
    M MacFarlane
    N Harper
    L M C Wheat
    M J S Dyer
    G M Cohen
    Cell Death & Differentiation, 2004, 11 : S193 - S206
  • [45] Human aortic valvular interstitial cells apoptosis and calcification: TNF-related apoptosis-inducing ligand (TRAIL) involvement
    Galeone, A.
    Brunetti, G.
    Oranger, A.
    Greco, G.
    Colucci, S.
    Zallone, A.
    Paparella, D.
    Grano, M.
    BONE, 2012, 50 : S70 - S70
  • [46] Enhancment of TNF-related apoptosis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents.
    Jones, DT
    Wickremasinghe, RG
    Mehta, AB
    Prentice, HG
    Ganeshaguru, K
    BLOOD, 2000, 96 (11) : 79A - 79A
  • [47] Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
    U Bertsch
    C Röder
    H Kalthoff
    A Trauzold
    Cell Death & Disease, 2014, 5 : e1390 - e1390
  • [48] Role of TRAIL (TNF-related apoptosis-inducing ligand) and its decoy receptors in the inflammatory response of acute myocardial infarction
    Soares, F. C.
    Saraiva, F.
    Lourenco, C. N.
    Antonio, N.
    Matos, V.
    Calisto, J.
    Faria, H.
    Paiva, A.
    Goncalves, L.
    Providencia, L. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 36 - 36
  • [49] Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
    Bertsch, U.
    Roeder, C.
    Kalthoff, H.
    Trauzold, A.
    CELL DEATH & DISEASE, 2014, 5 : e1390 - e1390